Cell Therapy Limited entered into a non binding letter of agreement to acquire Ashington Innovation in a reverse merger transaction PLC for approximately £140 million.

Cell Therapy Limited entered into a non binding letter of agreement to acquire Ashington Innovation PLC in a reverse merger transaction for approximately £140 million on August 17, 2023. The transaction is subject to regulatory approvals from the FCA and shareholders approval of Ashington Innovation PLC.